Therapeutic Recombinant Antibody Development with Next Generation Proprietary CHO Expression System

Antibodies are widely used in several applications of biomedical research and therapeutics. The increasing antibodies demand for higher quantity and quality in these areas, especially in cancer therapy, changing the production way of traditional hybridoma derived-antibody to recombinant antibody.

Recombinant antibody is generated in vitro using synthetic gene of interest into a host expression system – bacteria, yeast, insect or mammalian cell lines. The choice of the expression system affects the yield and functionality of the recombinant antibody. Chinese Hamster Ovary (CHO) cells remain the biopharmaceutical industry’s leading workhorse for many therapeutic protein productions.

Related services

Speaker-related Webinars

Therapeutic Recombinant Antibody Development with Next Generation Proprietary CHO Expression System

Therapeutic Recombinant Antibody Development with Next Generation Proprietary CHO Expression System

Learn More